SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)
[LOGO NEWS RELEASE Skystar Bio-Pharmaceutical Announces Revenue of $20.9 Million For Third Quarter Fiscal Year 2011 Revenues up 12.6%; Net Income up 16.2%; EPS of $1.08 Per Basic and Fully Diluted Share XI’AN, CHINA – November 14, 2011 -- - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), Third Quarter 2011 Highlights · Revenue increases 13% YoY to record $20.9]